Latest Articles
Future of cancer treatment in PD-1 subcutaneous injections - Medical News Today
Future of cancer treatment in PD-1 subcutaneous injections Medical News Today
Published: April 4, 2025, 5 p.m.
Revolutionary AI spots nearly 100% of cancers, beating doctors - AOL.com
Revolutionary AI spots nearly 100% of cancers, beating doctors AOL.com
Published: April 4, 2025, 12:53 p.m.
Endometrial Cancer Treatment Market 2034: Clinical Trials, - openPR.com
Endometrial Cancer Treatment Market 2034: Clinical Trials, openPR.com
Published: April 4, 2025, 4:30 a.m.
SGO 2025: Impact of Precision Medicine in Endometrial Cancer - Medscape
SGO 2025: Impact of Precision Medicine in Endometrial Cancer Medscape
Published: April 3, 2025, 5:21 p.m.
Metformin Plus Letrozole & Abemaciclib Appears Safe, Effective in Endometrial Cancer - Oncology Nurse Advisor
Metformin Plus Letrozole & Abemaciclib Appears Safe, Effective in Endometrial Cancer Oncology Nurse Advisor
Published: April 3, 2025, 4 a.m.
Testicular Cancer Awareness - Get Me Giddy
Testicular Cancer Awareness Get Me Giddy
Published: April 2, 2025, 3:46 a.m.
Buy Rating Reaffirmed for Acrivon Therapeutics Amid Promising Endometrial Cancer Data and Strong Financial Position - TipRanks
Buy Rating Reaffirmed for Acrivon Therapeutics Amid Promising Endometrial Cancer Data and Strong Financial Position TipRanks
Published: April 1, 2025, 6:54 p.m.
Cervical cancer: Prevention through awareness, screening - Northside Hospital
Cervical cancer: Prevention through awareness, screening Northside Hospital
Published: April 1, 2025, 3:28 p.m.
Excess heme orchestrates progesterone resistance in uterine endometrial cancer through macrophage polarization and the IL-33/PAX8/PGR axis - ScienceDirect.com
Excess heme orchestrates progesterone resistance in uterine endometrial cancer through macrophage polarization and the IL-33/PAX8/PGR axis ScienceDirect.com
Published: April 1, 2025, 2:47 p.m.
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR - Nature
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR Nature
Published: April 1, 2025, 1:15 p.m.
Link copied to clipboard!